MEDNAX, Inc. (MD) EPS Estimated At $0.91

October 14, 2018 - By Marguerite Chambers

MEDNAX, Inc. (NYSE:MD) Logo

Analysts expect MEDNAX, Inc. (NYSE:MD) to report $0.91 EPS on November, 7.They anticipate $0.09 EPS change or 10.98 % from last quarter’s $0.82 EPS. MD’s profit would be $80.29 million giving it 12.19 P/E if the $0.91 EPS is correct. After having $0.99 EPS previously, MEDNAX, Inc.’s analysts see -8.08 % EPS growth. The stock decreased 0.94% or $0.42 during the last trading session, reaching $44.37. About 1.00M shares traded or 37.14% up from the average. MEDNAX, Inc. (NYSE:MD) has risen 10.78% since October 14, 2017 and is uptrending. It has underperformed by 4.84% the S&P500.

MEDNAX, Inc. (NYSE:MD) Ratings Coverage

Among 4 analysts covering Mednax (NYSE:MD), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Mednax had 6 analyst reports since May 4, 2018 according to SRatingsIntel. The firm earned “Neutral” rating on Monday, May 7 by Credit Suisse. Citigroup maintained MEDNAX, Inc. (NYSE:MD) on Friday, May 4 with “Neutral” rating. Bank of America upgraded MEDNAX, Inc. (NYSE:MD) rating on Tuesday, September 18. Bank of America has “Neutral” rating and $55 target. The rating was upgraded by Leerink Swann on Monday, September 24 to “Outperform”. The firm has “Outperform” rating by Credit Suisse given on Friday, August 3.

MEDNAX, Inc., together with its subsidiaries, provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the United States and Puerto Rico. The company has market cap of $3.92 billion. The firm offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care; and acute and chronic pain management services. It has a 11.97 P/E ratio. It also provides maternal-fetal care, including inpatient and office clinical care to expectant mothers and their unborn babies through maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians consisting of maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors.

More important recent MEDNAX, Inc. (NYSE:MD) news were published by: Seekingalpha.com which released: “MEDNAX acquires large neonatology practice in South Florida” on October 10, 2018, also Nasdaq.com published article titled: “Recent Analysis Shows Party City Holdco, Commercial Metals, MRC Global, DISH Network, Mednax, and Old Republic …”, Seekingalpha.com published: “Leerink bullish on MEDNAX, shares up 2%” on September 24, 2018. More interesting news about MEDNAX, Inc. (NYSE:MD) was released by: Seekingalpha.com and their article: “MEDNAX acquires leading Nevada Radiology practice” with publication date: October 02, 2018.

MEDNAX, Inc. (NYSE:MD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>